Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526435 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Walk With Ease in Arthritis
A Phase 3 study of Arthritis, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 3
- Development phase
- 468
- Enrollment target
- 1
- Study location
NCT00526435: Completed Phase 3 study of Arthritis, sponsored by Centers for Disease Control and Prevention.
NCT00526435 is a Phase 3 study of Arthritis that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 468 participants, below the 4,500-participant average among 48 other Arthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00526435, a Phase 3 study of Arthritis, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 468 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to determine the whether the Walk with Ease (WWE) program in its 2 version (group-assisted and self-directed) can increase physical activity and fitness levels among individuals (18 years and older) with arthritis over the long-term. Participants will be approximately 657 subjects from 20-24 rural and urban communities across North Carolina. It is expected that participants in the WWE program will have reduced pain, improved function and increased activity levels after participation in this 6-week program.
Conditions Studied
Interventions
- BEHAVIORAL Walk with Ease - Group
- BEHAVIORAL Walk with Ease - Self
Study Locations (1)
North Carolina
- University of North Carolina - Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
What the finished NCT00526435 record still lists
NCT00526435 is an interventional study that assigns participants to a tested intervention. The registered 468 participants enrollment target is mid-sized for trials with a published cap, below the 4,500-participant average among 48 other Arthritis trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Walk with Ease - Group is the first listed.
NCT00526435 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00526435 about?
NCT00526435 is a clinical study titled "Evaluation of Walk With Ease in Arthritis". The overall goal of this study is to determine the whether the Walk with Ease (WWE) program in its 2 version (group-assisted and self-directed) can increase physical activity and fitness levels among individuals (18 years and older) with arthritis over the long-term. Participants will be approximate...
What is the current status of trial NCT00526435?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 468 participants. The study started on 2007-10. Estimated completion is 2010-01.
What conditions does trial NCT00526435 study?
This clinical trial studies the following conditions: Arthritis.
What interventions are being tested in trial NCT00526435?
The interventions under investigation include: Walk with Ease - Group (BEHAVIORAL), Walk with Ease - Self (BEHAVIORAL).
Who is sponsoring clinical trial NCT00526435?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00526435 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00526435's enrollment target sits among peer trials
468 9th of 48 higher than 40 of 48 other Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
COMPLETED · Phase 3
-
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
RECRUITING
-
Expanding Exercise Programming for Veterans Through Telehealth
RECRUITING · NA
-
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
RECRUITING
-
Evaluation of the Walk With Ease Program for Fall Prevention
RECRUITING · Phase 1
-
Ultralow Dose PET Imaging for 18F-NaF Uptake
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03124303 · 468 participants
Interventions for Postoperative Delirium: Biomarker-3
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
- NCT05357170 · 468 participants
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia